EXAGEN INC. Quarterly Costs and Expenses in USD from Q3 2018 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Total costs of sales and operating expenses for the period.
Summary: Exagen Inc. quarterly/annual Costs and Expenses history and growth rate from Q3 2018 to Q3 2024.
Exagen Inc. Costs and Expenses for the quarter ending September 30, 2024 was $17.2M, a 7.11% decline year-over-year.
Exagen Inc. Costs and Expenses for the twelve months ending September 30, 2024 was $71.2M, a 15.1% decline year-over-year.
Exagen Inc. annual Costs and Expenses for 2023 was $75.4M, a 17.7% decline from 2022.
Exagen Inc. annual Costs and Expenses for 2022 was $91.6M, a 26.6% increase from 2021.
Exagen Inc. annual Costs and Expenses for 2021 was $72.4M, a 26.6% increase from 2020.

Costs and Expenses, Trailing 12 Months (USD)

Costs and Expenses, Quarterly (USD)

Costs and Expenses, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q3 2024	$71.2M	$17.2M	-$1.32M	-7.11%	Jul 1, 2024	Sep 30, 2024	10-Q	2024-11-12
Q2 2024	$72.5M	$17.7M	-$1.4M	-7.35%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-05
Q1 2024	$73.9M	$17.4M	-$1.52M	-8.02%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-13
Q4 2023	$75.4M	$18.9M	-$8.42M	-30.8%	Oct 1, 2023	Dec 31, 2023	10-K	2024-03-18
Q3 2023	$83.8M	$18.5M	-$4.06M	-18%	Jul 1, 2023	Sep 30, 2023	10-Q	2024-11-12
Q2 2023	$87.9M	$19.1M	-$2.62M	-12.1%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-05
Q1 2023	$90.5M	$18.9M	-$1.14M	-5.66%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-13
Q4 2022	$91.6M	$27.3M	+$8.39M	+44.3%	Oct 1, 2022	Dec 31, 2022	10-K	2024-03-18
Q3 2022	$83.2M	$22.5M	+$3.79M	+20.2%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-13
Q2 2022	$79.4M	$21.7M	+$3.16M	+17%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-07
Q1 2022	$76.3M	$20.1M	+$3.92M	+24.3%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-15
Q4 2021	$72.4M	$18.9M	+$3.51M	+22.8%	Oct 1, 2021	Dec 31, 2021	10-K	2023-03-20
Q3 2021	$68.9M	$18.8M	+$4.19M	+28.8%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-21
Q2 2021	$64.7M	$18.5M	+$6.15M	+49.7%	Apr 1, 2021	Jun 30, 2021	10-Q/A	2022-11-21
Q1 2021	$58.5M	$16.2M	+$1.35M	+9.11%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-11
Q4 2020	$57.2M	$15.4M	+$2.36M	+18%	Oct 1, 2020	Dec 31, 2020	10-K	2022-03-22
Q3 2020	$54.8M	$14.6M	+$1.97M	+15.6%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-10
Q2 2020	$52.8M	$12.4M	-$519K	-4.03%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-09
Q1 2020	$53.4M	$14.8M	+$3.67M	+33%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-11
Q4 2019	$49.7M	$13.1M			Oct 1, 2019	Dec 31, 2019	10-K	2021-03-16
Q3 2019		$12.6M	+$3.24M	+34.6%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-10
Q2 2019		$12.9M			Apr 1, 2019	Jun 30, 2019	10-Q	2020-07-28
Q1 2019		$11.1M			Jan 1, 2019	Mar 31, 2019	10-Q	2020-05-11
Q3 2018		$9.36M			Jul 1, 2018	Sep 30, 2018	10-Q	2019-11-12

* An asterisk sign (*) next to the value indicates that the value is likely invalid.